Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Beijer Byggmaterial in connection with the acquisition of Kakeldax
Mandate

Vinge advises Beijer Byggmaterial in connection with the acquisition of Kakeldax

September 07, 2021 Employment and Benefits M&A Real Estate and Construction Corporate Commercial Intellectual Property

Vinge has advised Beijer Byggmaterial AB in connection with the acquisition of the Kakeldax group. The Kakeldax group consists of three strong brands – Stigs Kakel, Kakeldax and Kakelcentralen.

The group has more than 30 years of industry experience with 11 own stores, web shops and distributors across the country. The head office and central storage facility are located in Gothenburg.

Vinge’s team consisted of, among others, Jonas Bergström, Joacim Rydergård, Vilhelm Rondahl, Ellinor Wargenbrant and Beatrice Randow (M&A), Hedvig Ekdahl (Corporate Commercial), Frida Ställborn (Real Property/Lease Agreements), Lina Österberg (Environment), Karl-Hugo Engdahl (GDPR), Ebba Svenburg and Elin Broman (Employment Law), Felizia Wiker (IP) and Nathalie Hughes (VDR).

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025